Focusing on therapeutic strategies that target collagen production and maturation, in particular on the role of extracellular matrix protein accumulation and collagen deposition in idiopathic pulmonary fibrosis pathogenesis. Characterization of the expression and function of Prolyl-3-hydroxylase 4 (P3H4) in lung fibrosis in both mouse and human tissue, and primary human lung fibroblast culture models. Evaluation of P3H4 as a novel player in collagen synthesis and secretion in lung fibroblasts and a new drug target for idiopathic pulmonary fibrosis. Establishing a new protocol for simultaneous RNA and protein extraction from mouse tail tenocytes in P3H1 null and WT mice followed by gene expression analysis. Extensive knowledge and expertise in the use of conditional knockout mice.

preparing an annual budget, requesting pharmaceutical purchases, placing orders for medicines through medical stores, and managing pharmaceuticals, medical supplies, equipment purchasing, and stock.